Iambic Therapeutics Expands Leadership Team With the Appointment of Neil Josephson, MD as Chief Medi
Interim CMO Dr. Jackie Walling to join Iambic’s Clinical Advisory BoardSAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a biotechnology company developing novel therapeutics using its AI-driven discovery platform, today announced the appointment of oncologist and industry veteran Neil Josephson, M.D., as its Chief M...
Source: pharmiweb.com